MGTX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
MeiraGTx Holdings PLC (MGTX) is not a strong buy at the moment for a beginner, long-term investor. The technical indicators show a bearish trend, and the company's financials reveal significant revenue declines and negative net income, which are concerning for long-term growth. While hedge funds are buying, insiders remain neutral, and there is no recent news or congress trading data to act as a positive catalyst. Analysts maintain a Buy rating with a reduced price target, but the lack of strong proprietary trading signals and weak financial performance suggest holding off on this stock for now.
The stock is in a bearish trend with the MACD histogram below 0 and negatively expanding, RSI at 19.95 indicating oversold conditions, and bearish moving averages (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level of 6.853, with resistance at 7.365.
Hedge funds are buying, with an 869.70% increase in buying over the last quarter. Analysts maintain a Buy rating, and the biotech sector is seeing improved access to capital and positive data catalysts.
The company reported a significant revenue drop of -96.24% YoY in Q3 2025, and gross margin fell by -340.20% YoY. No recent news or congress trading data is available, and technical indicators show bearish momentum.
In Q3 2025, revenue dropped to $410,000 (-96.24% YoY), net income improved to -$50.51M (+28.43% YoY), EPS increased to -0.62 (+12.73% YoY), and gross margin dropped to 23.66 (-340.20% YoY).
BofA maintains a Buy rating but lowered the price target from $15 to $14, citing positive data catalysts and improved biotech sector conditions but expressing concerns about the sustainability of these trends.
